---
$id: https://graph.org.ai/products/commodity/51413108
$type: Product
source: UNSPSC
code: "51413108"
title: "Udenafil"
class: "51413100"
classTitle: "Vasodilator quinazolines and quinolines and quinolones and sulfonamides and triazines"
family: "51410000"
familyTitle: "Vasodilators"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Udenafil

**UNSPSC Code**: 51413108
**Class**: [Vasodilator quinazolines and quinolines and quinolones and sulfonamides and triazines](Vasodilator quinazolines and quinolines and quinolones and sulfonamides and triazines.mdx)
**Family**: [Vasodilators](../Vasodilators.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cgmp phosphodiesterase inhibitor, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier L5IB4XLY36. European Medicines Agency schedules Udenafil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32099. Udenafil generally arises in the molecular formula C25H36N6O4S. The term UDENAFIL is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, volume 20, no. 1, 2006, list 55.) UDENAFIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

